StonvexLoading…
StonvexStonvexStonvexCore line items from CHCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $1.22M | $4.16M | $3.58M | $2.92M |
Operating Income | Not available | Not available | Not available | $32.91M |
Net Income | $-3.18M | $7.71M | $22.02M | $22.49M |
EPS (Diluted) | $-0.23 | $0.20 | $0.81 | $0.87 |
Total Assets | $992.56M | $945.41M | $876.42M | $754.23M |
Total Liabilities | $516.60M | $432.16M | $379.61M | $292.12M |
Cash & Equivalents | $4.38M | $3.49M | $11.23M | $2.35M |
Free Cash Flow OCF − CapEx | $34.24M | $42.40M | $49.90M | $49.13M |
Shares Outstanding | 28.24M | 27.61M | 25.90M | 24.98M |